Z-3330-2026 Class II Ongoing
FDA device recall Z-3330-2026 was initiated by Tandem Diabetes Care, Inc. on Jul 16, 2026 and is designated Class II. Reason for recall: A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P)… The recall status is ongoing. Affected quantity: 177.
Recall details
- Product Type
- Devices
- Report Date
- Oct 7, 2026
- Initiation Date
- Jul 16, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 177
Product description
Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.13 UDI-DI: 00389152470740 Component: No
Reason for recall
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.
Distribution pattern
US Nationwide distribution.
Code information
Lot Code: UDI-DI: 00389152470641 Software Version: 2.13 (iOS only)
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-3330-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026